• yd12399云顶

    Recent Highlight

    Thermo-immune synergy: Camrelizumab plus microwave ablation in preoperative early-stage breast cancer

    Med . 2024 Apr 12;5(4):278-280.

    2024-04-12

    Selected Publications

    2024-04-25

    Efficacy and Safety of Neoadjuvant Pyrotinib for Human Epidermal Receptor 2-Positive Breast Cancer: A Meta-Analysis

    Tohoku J Exp Med . 2024 Apr 25.

    2024-04-24

    Long survival after neoadjuvant and adjuvant camrelizumab plus chemotherapy and surgery in a patient with hepatoid adenocarcinoma of the lung: A case report

    Hum Vaccin Immunother . 2024 Dec 31;20(1):2342133.

    2024-04-23

    Design, synthesis, and structure-activity relationship study of novel plinabulin derivatives as anti-tumor agents based on the co-crystal structure

    Mol Divers . 2024 Apr 23.

    2024-04-20

    The emerging therapies are reshaping the first-line treatment for advanced hepatocellular carcinoma: a systematic review and network meta-analysis

    Therap Adv Gastroenterol . 2024 Apr 20:17:17562848241237631.

    2024-04-16

    Author Correction: Camptothecin enhances the anti-tumor effect of low-dose apatinib combined with PD-1 inhibitor on hepatocellular carcinoma

    Sci Rep . 2024 Apr 16;14(1):8787.

    2024-04-15

    Primary Pulmonary Lymphoepithelioma-like Carcinoma: A Case Report Utilizing Camrelizumab and Anlotinib for Prolonged Survival

    Anticancer Agents Med Chem . 2024 Apr 15.

    More
    By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and facilitate our marketing efforts. For more information about the use of cookies, please see the cookies notice web page.
    Set Preferences
    Strictly necessary cookies (also called “technical cookies”)
    They allow you to browse a website, a platform or an app, and to use the various options or services on it (e.g., control traffic, identify data or session, access to restricted access sections or content, etc.). Necessary cookies should always be enabled. These cookies help make a website usable by enabling basic functions like page navigation and secure connection to the website. The website cannot function properly without these cookies.
    Cookie Name Type Purpose Cookie Placed by Retention Period
    Path Strictly necessary Backend need the current domain name www.hengrui.com Session
    TS01a35966 Strictly necessary This cookie is set for security and anti-fraud purposes. www.hengrui.com Session
    TS01148872 Strictly necessary This cookie is set for security and anti-fraud purposes. www.hengrui.com Session
    TS6ce60bb6027 Strictly necessary This cookie is set for security and anti-fraud purposes. www.hengrui.com Session
    .ASPXANONYMOUS Strictly necessary This cookies is set by ASP.NET and is used to track users within a session without requiring the user to log in. www.hengrui.com 100,000 Mins
    BIGipServer~c_p1~c_
    dmzapp01~c_pool_
    dmzapp01
    Strictly necessary This cookie is set for security and anti-fraud purposes. www.hengrui.com Session
    Functional cookies
    They help Hengrui to make the website usable by providing you some basic features and by remembering your preferences and choices of using Hengrui’s website (e.g., language, the region from where the service is accessed, etc.). Not accepting cookies may cause slow website performance or poorly adapted recommendations.
    Statistics Cookies
    They allow Hengrui to have a better understanding of how you interact with the website (e.g., which pages are visited the most) in order to optimize the functioning of the website. These cookies collect information about how visitors use a website, for instance which pages visitors go to most often and if they receive error messages.
    Marketing Cookies
    They enable Hengrui to monitor your behaviour on the website. The aim is to display advertisements that are meaningful and attractive to you and therefore more useful to third party publishers and advertisers, as well as to make promotional and specific information available to you on the website.

    CONTACT

    Service Hotline: +86 400-828-3900
    Report adverse events: pv.post-marketing@hengrui.com

    CONTACT

    Service Hotline: +86 400-828-3900
    Report adverse events: pv.post-marketing@hengrui.com

    ©2021 Jiangsu Hengrui Pharmaceuticals Co., Ltd. All rights reserved 苏ICP备11027260号-13互联网资格证书:(苏)-非经营性-2023-0040

    苏公网安备 32070402010095号

    ©2021 Jiangsu Hengrui Pharmaceuticals Co., Ltd. All rights reserved

    苏ICP备11027260号-13互联网资格证书:(苏)-非经营性-2023-0040

    苏公网安备 32070402010095号